Lupin cash flow

Latest FY26

Cash from operations: ₹7,546cr+1,655.0% on FY25
Capital spending: ₹2,055cr+22.1% on FY25
Free cash flow: ₹5,491cr−₹1,252 cr in FY25
Cash from financing: −₹846cr₹1,732 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	1,376	1,169	1,197	881
	—	434	295	312	274
	—	−219	−136	−46.2	−32.4
	—	−59.3	−1.3	5.2	−1.8
	—	39.0	42.3	38.3	40.8
	—	−410	−38.2	−21.0	−33.9
	—	63.9	12.3	12.8	2.4
	—	−129	−41.7	−30.8	−32.7
	—	−586	−541	−440	195
	—	−739	−781	−241	−132
	—	−223	303	−112	−191
	—	5.3	−29.4	10.5	−39.4
	—	−286	−190	48.5	68.4
	—	14.7	−0.5	32.3	−13.1
	—	211	−2,570	−158	37.1
	—	1,191	1.1	419	217
	—	362	86.4	42.9	13.9
	—	0.9	−41.1	25.5	0.7
	—	505	0.1	268	152
	—	52.8	15.8	29.1	23.8
	—	287	−251	9.0	25.6
	—	49.2	17.0	−6.0	5.0
Cash from operating activities
	7,474	6,873	4,015	2,422	716
	—	1,940	−2,679	1,394	1,461
	—	8,813	1,336	3,816	2,177
	—	1,267	906	326	243
	—	7,546	430	3,490	1,934
Cash from investing activities
	—	2,055	1,682	929	1,500
	—	248	29.4	12.3	38.5
	—	136	46.3	147	291
	—	30.7	0.0	0.0	0.0
	—	217	130	46.2	32.4
	—	−2,380	−32.4	−537	396
	—	−4,076	−1,602	−1,554	−1,324
Cash from financing activities
	—	16.5	39.9	0.0	0.0
	—	0.0	0.0	14.6	1.9
	—	279	2,428	0.0	286
	—	0.0	0.0	1,617	113
	—	164	141	116	103
	—	361	230	283	226
	—	548	365	183	183
	—	−67.1	0.0	0.0	0.0
	—	−846	1,732	−2,184	−337
	—	2,624	560	−248	273
	—	2,624	560	−248	273
	—	—	—	984	1,265
Reference items
	9,538	8,816	5,283	3,811	1,798
	31.8%	31.5%	23.3%	19.0%	10.8%
	5,491	5,491	−1,252	2,562	435
	—	5,963	925	704	—
	₹120.10	₹120.10	−₹27.39	₹56.03	₹9.50
	16.43×	—	—	—	—
	—	1.41×	0.13×	1.80×	4.32×
	—	1,267	906	326	243
	—	361	230	283	226

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LUPIN₹1,972.70

Lupin Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA CIPLA DRREDDY ALKEM FORTIS AUROPHARMA LAURUSLABS MANKINDMcap ₹90,192 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	880.7	1,196.8	1,169.3	1,375.5	—
+ Finance Costs	274.3	311.6	294.9	434.5	—
+ Interest Income	-32.4	-46.2	-136.0	-218.6	—
+ Fair Value (Gains) / Losses	-1.8	5.2	-1.3	-59.3	—
+ Share-based Payments	40.8	38.3	42.3	39.0	—
+ Unrealised FX (Gain) / Loss	-33.9	-21.0	-38.2	-410.1	—
+ Other Non-cash Items	2.4	12.8	12.3	63.9	—
+ Other — Cash Effects are Investing / Financing	-32.7	-30.8	-41.7	-129.2	—
Changes in Working Capital
+ Inventories	195.4	-440.2	-541.2	-585.9	—
+ Trade Receivables — Current	-132.0	-240.8	-780.9	-738.8	—
+ Other Financial Assets — Current	-191.2	-112.4	302.8	-223.4	—
+ Other Financial Assets — Non-current	-39.4	10.5	-29.4	5.3	—
+ Other Current Assets	68.4	48.5	-189.8	-285.5	—
+ Other Non-current Assets	-13.1	32.3	-0.5	14.7	—
+ Other Bank Balances	37.1	-157.9	-2,570.0	211.1	—
+ Trade Payables — Current	216.8	418.8	1.1	1,190.6	—
+ Other Financial Liabilities — Current	13.9	42.9	86.4	361.7	—
+ Other Financial Liabilities — Non-current	0.7	25.5	-41.1	0.9	—
+ Other Current Liabilities	152.2	268.3	0.1	505.3	—
+ Other Non-current Liabilities	23.8	29.1	15.8	52.8	—
+ Provisions — Current	25.6	9.0	-250.8	286.9	—
+ Provisions — Non-current	5.0	-6.0	17.0	49.2	—
Cash from Operating Activities
Profit Before Tax (per I/S)	716.5	2,422.3	4,015.0	6,872.6	7,474.4
+ Total Adjustments (incl. Working Capital)	1,460.8	1,394.2	-2,679.0	1,940.4	—
Cash from Operations (pre-tax)	2,177.3	3,816.5	1,336.0	8,813.0	—
+ Income Taxes Paid	243.2	326.1	906.0	1,267.4	—
Cash from Operating Activities	1,934.1	3,490.4	429.9	7,545.6	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	1,499.6	928.9	1,682.4	2,054.9	—
+ Disp of Fixed Assets	38.5	12.3	29.4	247.7	—
+ Acq of Subsidiaries / Businesses (net)	291.0	146.5	46.3	135.8	—
+ Disp of Subsidiaries / Businesses (net)	0.0	0.0	0.0	30.7	—
+ Interest Received — Investing	32.4	46.2	129.9	216.9	—
+ Other Inflows / (Outflows) — Investing	395.8	-537.4	-32.4	-2,380.4	—
Cash from Investing Activities	-1,323.9	-1,554.3	-1,601.9	-4,075.7	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	0.0	39.9	16.5	—
+ Proceeds from Exercise of Stock Options	1.9	14.6	0.0	0.0	—
+ Proceeds from Borrowings	286.3	0.0	2,427.7	279.0	—
+ Repayment of Borrowings	113.5	1,617.1	0.0	0.0	—
+ Payment of Lease Liabilities	102.8	115.9	140.9	164.5	—
+ Interest Paid	226.4	282.9	229.5	361.5	—
+ Dividends Paid	182.5	182.8	365.3	548.3	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	0.0	-67.1	—
Cash from Financing Activities	-337.0	-2,184.2	1,731.9	-845.9	—
Net Changes in Cash (pre-FX)	273.2	-248.1	559.9	2,624.0	—
Net Changes in Cash	273.2	-248.1	559.9	2,624.0	—
Closing Cash	1,264.6	983.8	—	—	—
Reference Items
EBITDA	1,798.1	3,810.5	5,283.3	8,816.0	9,538.3
EBITDA Margin %	10.80	19.04	23.27	31.53	31.83
Free Cash Flow (CFO − Capex)	434.5	2,561.5	-1,252.5	5,490.8	5,490.8
Free Cash Flow to Equity	—	704.5	924.7	5,962.9	—
Free Cash Flow per Basic Share	9.50	56.03	-27.39	120.10	120.10
Price to Free Cash Flow	—	—	—	—	16.43
Cash Flow to Net Income	4.32	1.80	0.13	1.41	—
Cash Paid for Taxes	243.2	326.1	906.0	1,267.4	—
Cash Paid for Interest	226.4	282.9	229.5	361.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.